Valero-Elizondo, Javier
Javed, Zulqarnain
Khera, Rohan
Tano, Mauricio E.
Dudum, Ramzi
Acquah, Isaac
Hyder, Adnan A.
Andrieni, Julia
Sharma, Garima
Blaha, Michael J.
Virani, Salim S.
Blankstein, Ron
Cainzos-Achirica, Miguel
Nasir, Khurram
Article History
Received: 5 April 2022
Accepted: 10 October 2022
First Online: 6 December 2022
Declarations
:
: Given the public availability and de-identified nature of the NHIS data, this study was exempt from the purview of Houston Methodist Hospital’s Institutional Review Board Committee. No extramural funding was used to support this work. No experiments on humans were carried, and no human tissue samples were examined.
: Not applicable.
: Dr. Nasir is on the advisory board of Amgen, Novartis, Novo Nordisk, and his research is partly supported by the Jerold B. Katz Academy of Translational Research. Dr. Khera receives support from the National Heart, Lung, and Blood Institute of the National Institutes of Health under award, 1K23HL153775. Dr. Virani is supported by the Department of Veterans Affairs, the World Heart Federation, and the Tahir and Jooma Family; and receives honoraria from the American College of Cardiology as Associate Editor for Innovations. No other conflicts of interest relevant to the content of this manuscript were reported by the authors.